NTRA - יחס חוב להיוון בספרים Natera Inc

Natera, Inc. (NTRA) is a leading player in genetics whose success is based on unique datasets and non-invasive screening. The issuer is expanding its service profile from reproduction to oncology monitoring, thereby minimizing risks. A focus on the US domestic market eliminates external political pressure. The debt-to-market cap ratio on GURU.Markets yields the current status of 0.13, demonstrating the business's financial stability.

This metric reflects leverage dynamics, measuring the proportion of borrowed funds relative to equity to assess the business's financial stability. This ratio of debt obligations to balance sheet capital demonstrates how aggressively Natera, Inc. (NTRA) is financing its expansion into the high-margin oncology testing segment, allowing investors to promptly identify a critical increase in debt load amid the company's rapid scaling.